MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
attributable to common...
-$5,485K
(-675.55%↓ Y/Y)
Net income (loss)
-$5,465K
(-671.65%↓ Y/Y)
Convertible and redeemable
preferred stock deemed...
$20K
(766.67%↑ Y/Y)
Income tax expense
-$1K
Income (loss) before
income tax expense
-$5,466K
(-671.76%↓ Y/Y)
Income (loss) from
operations
-$4,569K
(-1497.25%↓ Y/Y)
Total other income
(expense), net
-$897K
(-242.61%↓ Y/Y)
Product sales, net
$899K
(6.39%↑ Y/Y)
Interest income
$2K
(-75.00%↓ Y/Y)
Total operating
expenses
$5,468K
(955.60%↑ Y/Y)
Other expense, net
$737K
(22.83%↑ Y/Y)
Change in fair value of
financial instruments
-$162K
(-113.27%↓ Y/Y)
General and
administrative
$2,372K
(0.30%↑ Y/Y)
Selling and marketing
$2,093K
(-19.50%↓ Y/Y)
Research and
development, net
$518K
(110.29%↑ Y/Y)
Cost of goods sold
$410K
(12.33%↑ Y/Y)
Amortization of intangible
asset
$75K
(-66.37%↓ Y/Y)
Back
Back
Income Statement
Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. (EVFM)
source: myfinsight.com